Dr Frances Brightman is a computational biology specialist, with 14 years’ post-doctoral experience in both commercial and academic environments. In 2001 she was awarded a PhD from Oxford Brookes University, where she worked with Professor David Fell on the modelling and simulation of cell signalling processes.
For the next seven years Frances was employed by Cyprotex, a CRO specialising in preclinical ADME toxicology, to formulate, implement and validate physiologically-based pharmacokinetic (PBPK) models; she subsequently returned to David Fell’s group at Oxford Brookes University for three years to investigate dynamic modelling and quantitative analysis of mammalian mitochondrial metabolism.
Frances joined Physiomics in September 2010 as a senior simulation scientist and was promoted to Project leader in 2014.
Interested in speaking with a consultant?
We’ll arrange a brief consultation for you with a specialist in our team.